Back

Extended prospective follow-up of a randomised comparison of riociguat and selexipag under multimodal therapy in inoperable chronic thromboembolic pulmonary hypertension

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Management of chronic thromboembolic pulmonary hypertension Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Yoshihisa Nakano

Nagoya University Hospital, Nagoya (Japan)

6 More presentations in this session

Presentation thumbnail
Temporal evolution of multidisciplinary management for chronic thromboembolic pulmonary hypertension: a 30-year experience at a refererral center
Doctor M. Coronel (Corrientes, AR)
Abstract
Presentation thumbnail
Prediction of treatable occluded branches before balloon pulmonary angioplasty using CT imaging in patients with chronic thromboembolic pulmonary hypertension
Assistant Professor H. Hashimoto (Tokyo, JP)
Abstract
Presentation thumbnail
Cumulative institutional experience and the learning curve of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Doctor R. Takano (Suita, JP)
Abstract
Presentation thumbnail
Progressive lesion-level hemodynamic improvement from immediate post-procedural assessment to follow-up after balloon pulmonary angioplasty
Assistant Professor Y. Nakano (Nagoya, JP)
Abstract
Presentation thumbnail
Comparable exercise hemodynamic improvements with riociguat and selexipag under multimodal therapy including balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension
Mrs T. Sugiyama (Nagoya, JP)
Abstract

Access the full session

Session thumbnail
Management of chronic thromboembolic pulmonary hypertension

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of selexipag in patients with pulmonary arterial hypertension in real-life: early results of RAMPHA study
22 May 2022
thumbnail
Congress Presentation
Balloon pulmonary angioplasty for patients with symptomatic chronic thromboembolic disease without pulmonary hypertension
3 September 2019
thumbnail
Congress Presentation
Shift in transcriptional landscape of human right ventricle in chronic thromboembolic pulmonary arterial hypertension
28 August 2020
thumbnail
Congress Presentation
Switching sildenafil to riociguat in chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty - the S2R study
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources